Stiolto Respimat (tiotropium bromide/olodaterol) has just been approved by the FDA for the maintenance treatment of COPD, and should be available in pharmacies soon.
Stiolto (tiotropium/olodaterol) is used to treat chronic obstructive pulmonary disease, including chronic bronchitis or emphysema. Stiolto is more popular than other anticholinergic/beta agonist combinations. There are currently no generic alternatives to Stiolto.
Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Stiolto is covered by most Medicare and insurance plans.
Tiotropium and Olodaterol Latest News
Get the latest updates on this drug from the GoodRx medical team